{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:56:12Z","timestamp":1792990572804,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010816","name":"Anhui Science and Technology Department","doi-asserted-by":"publisher","award":["202204295107020008"],"award-info":[{"award-number":["202204295107020008"]}],"id":[{"id":"10.13039\/501100010816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010814","name":"Anhui Province Department of Education","doi-asserted-by":"publisher","award":["2022AH010070"],"award-info":[{"award-number":["2022AH010070"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82120108012"],"award-info":[{"award-number":["82120108012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930086"],"award-info":[{"award-number":["81930086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jhep.2025.07.016","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T19:57:45Z","timestamp":1754423865000},"page":"355-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"84","author":[{"given":"Jianbo","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuze","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zetao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senlin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rundi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beicheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8657-7024","authenticated-orcid":false,"given":"Zechuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.07.016_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.07.016_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.07.016_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","article-title":"Pathogenesis of cholangiocarcinoma","volume":"16","author":"Rodrigues","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jhep.2025.07.016_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jhep.2025.07.016_bib5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.6004\/jnccn.2014.0112","article-title":"Hepatobiliary cancers, version 2.2014","volume":"12","author":"Benson","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jhep.2025.07.016_bib6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2468-1253(21)00171-0","article-title":"Current and emerging therapies for advanced biliary tract cancers","volume":"6","author":"Kam","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.07.016_bib7","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jhep.2025.07.016_bib8","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jamaoncol.2021.3836","article-title":"Final overall survival efficacy results of ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation: the phase 3 randomized clinical ClarIDHy trial","volume":"7","author":"Zhu","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhep.2025.07.016_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.jhep.2025.07.016_bib10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.29350","article-title":"Role of ErbB\/HER family of receptor tyrosine kinases in cholangiocyte biology","volume":"67","author":"Pellat","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.07.016_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.bjc.6604129","article-title":"Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma","volume":"98","author":"Yoshikawa","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2025.07.016_bib12","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.3748\/wjg.14.7033","article-title":"Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma","volume":"14","author":"Sirica","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.07.016_bib13","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S1470-2045(10)70247-3","article-title":"Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study","volume":"11","author":"Gruenberger","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.07.016_bib14","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/annonc\/mdt337","article-title":"Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology","volume":"24","author":"Borbath","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2025.07.016_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(11)70301-1","article-title":"Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.07.016_bib16","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/hep.30978","article-title":"Loss of xanthine oxidoreductase potentiates propagation of hepatocellular carcinoma stem cells","volume":"71","author":"Sun","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.07.016_bib17","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jhep.2023.06.022","article-title":"The XOR-IDH3alpha axis controls macrophage polarization in hepatocellular carcinoma","volume":"79","author":"Lu","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.07.016_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2025.07.016_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1182\/blood.2020005895","article-title":"Epidermal growth factor receptor\u2013dependent DNA repair promotes murine and human hematopoietic regeneration","volume":"136","author":"Fang","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2025.07.016_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1158\/2159-8290.CD-22-0376","article-title":"LZTR1 mutation mediates oncogenesis through stabilization of EGFR and AXL","volume":"13","author":"Ko","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2025.07.016_bib21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41467-018-03117-y","article-title":"EGF receptor kinase suppresses ciliogenesis through activation of USP8 deubiquitinase","volume":"9","author":"Kasahara","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2025.07.016_bib22","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1091\/mbc.e05-06-0560","article-title":"Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes","volume":"16","author":"Mizuno","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jhep.2025.07.016_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2005.01.008","article-title":"Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response","volume":"7","author":"Wei","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2025.07.016_bib24","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1158\/0008-5472.CAN-06-3063","article-title":"Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene","volume":"67","author":"Wei","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2025.07.016_bib25","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1242\/jcs.062661","article-title":"MUC1 regulates nuclear localization and function of the epidermal growth factor receptor","volume":"123","author":"Bitler","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jhep.2025.07.016_bib26","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/onc.2010.631","article-title":"Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells","volume":"30","author":"Merlin","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2025.07.016_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jtho.2023.10.017","article-title":"MUC1-C is a common driver of acquired Osimertinib resistance in NSCLC","volume":"19","author":"Haratake","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jhep.2025.07.016_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.immuni.2019.06.015","article-title":"The histone methyltransferase Setdb2 modulates macrophage phenotype and uric acid production in diabetic wound repair","volume":"51","author":"Kimball","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2025.07.016_bib29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.cell.2019.10.001","article-title":"Stress-induced metabolic disorder in peripheral CD4(+) T cells leads to anxiety-like behavior","volume":"179","author":"Fan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2025.07.016_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm.2614","article-title":"Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids","volume":"18","author":"Wang","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2025.07.016_bib31","doi-asserted-by":"crossref","first-page":"101882","DOI":"10.1016\/j.redox.2021.101882","article-title":"Xanthine oxidoreductase: one enzyme for multiple physiological tasks","volume":"41","author":"Bortolotti","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.jhep.2025.07.016_bib32","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41401-021-00800-7","article-title":"The double faced role of xanthine oxidoreductase in cancer","volume":"43","author":"Chen","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jhep.2025.07.016_bib33","first-page":"12","article-title":"Combined methylome and transcriptome analyses reveals potential therapeutic targets for EGFR wild type lung cancers with low PD-L1 expression","author":"Hu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2025.07.016_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/13543776.2023.2262176","article-title":"The next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders","volume":"33","author":"Li","year":"2023","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.jhep.2025.07.016_bib35","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1007\/s00018-015-2014-z","article-title":"MUC1 (CD227): a multi-tasked molecule","volume":"72","author":"Apostolopoulos","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jhep.2025.07.016_bib36","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1158\/0008-5472.CAN-18-3259","article-title":"MUC1-C integrates chromatin remodeling and PARP1 activity in the DNA damage response of triple-negative breast cancer cells","volume":"79","author":"Yamamoto","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2025.07.016_bib37","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/1535-7163.MCT-10-1050","article-title":"Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells","volume":"10","author":"Raina","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhep.2025.07.016_bib38","article-title":"Emerging roles of xanthine oxidoreductase in chronic kidney disease","volume":"13","author":"Korsmo","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jhep.2025.07.016_bib39","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","article-title":"New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity","volume":"319","author":"Furuhashi","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2026.05.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000}},{"DOI":"10.1016\/j.jhep.2026.05.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825023827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825023827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:57:28Z","timestamp":1777510648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825023827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0168827825023827"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.07.016","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}